These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. Carcaillon L; Gaussem P; Ducimetière P; Giroud M; Ritchie K; Dartigues JF; Scarabin PY J Thromb Haemost; 2009 Dec; 7(12):1972-8. PubMed ID: 19735443 [TBL] [Abstract][Full Text] [Related]
3. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Lip GY; Lowe GD; Rumley A; Dunn FG Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351 [TBL] [Abstract][Full Text] [Related]
4. [Hemostatic and fibrinolysis markers in the early phase of acute ischaemic stroke]. Soroka-Wojtaszko M; Dmoszyńska A; Słoma-Madej K; Grzaśko N Pol Arch Med Wewn; 2004 Nov; 112(5):1303-9. PubMed ID: 15773512 [TBL] [Abstract][Full Text] [Related]
6. Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia. Anzej S; Bozic M; Antovic A; Peternel P; Gaspersic N; Rot U; Tratar G; Stegnar M Thromb Res; 2007; 120(1):39-46. PubMed ID: 17034835 [TBL] [Abstract][Full Text] [Related]
7. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178 [TBL] [Abstract][Full Text] [Related]
8. [Hemostatic markers of endothelial injury in ischaemic stroke caused by large or small vessel disease]. Iskra T; Turaj W; Słowik A; Zwolińska G; Strojny J; Szczudlik A Pol Merkur Lekarski; 2006 Nov; 21(125):429-33. PubMed ID: 17345834 [TBL] [Abstract][Full Text] [Related]
9. Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke? Antovic J; Bakic M; Zivkovic M; Ilic A; Blombäck M Scand J Clin Lab Invest; 2002; 62(3):195-9. PubMed ID: 12088338 [TBL] [Abstract][Full Text] [Related]
10. Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project. Lip GY; Blann AD; Farooqi IS; Zarifis J; Sagar G; Beevers DG Blood Coagul Fibrinolysis; 2002 Jun; 13(4):339-47. PubMed ID: 12032400 [TBL] [Abstract][Full Text] [Related]
11. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men. Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157 [TBL] [Abstract][Full Text] [Related]
12. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958 [TBL] [Abstract][Full Text] [Related]
13. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345 [TBL] [Abstract][Full Text] [Related]
14. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Mari D; Parnetti L; Coppola R; Bottasso B; Reboldi GP; Senin U; Mannucci PM Thromb Haemost; 1996 Feb; 75(2):216-8. PubMed ID: 8815562 [TBL] [Abstract][Full Text] [Related]
15. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Wiseman S; Marlborough F; Doubal F; Webb DJ; Wardlaw J Cerebrovasc Dis; 2014; 37(1):64-75. PubMed ID: 24401164 [TBL] [Abstract][Full Text] [Related]
16. Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke. Rooth E; Wallen NH; Blombäck M; He S Thromb Res; 2011 Jan; 127(1):51-6. PubMed ID: 20950841 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. Alvarez-Perez FJ; Castelo-Branco M; Alvarez-Sabin J J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):986-92. PubMed ID: 21296900 [TBL] [Abstract][Full Text] [Related]
18. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG Int J Cardiol; 1995 Jun; 50(1):31-42. PubMed ID: 7558462 [TBL] [Abstract][Full Text] [Related]
19. Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia. Woodburn KR; Rumley A; Lowe GD; Pollock JG Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):272-8. PubMed ID: 7552524 [TBL] [Abstract][Full Text] [Related]
20. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]